GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Medicare/Medicaid MMM

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements. H.R.3 - Lower Drug Costs Now Act H.R.19 - Lower Costs, More Cures Act of 2019 H.R.259 - Medicaid Extenders Act of 2019 H.R. 7647 - To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage S.2543 - The Prescription Drug Pricing Reduction Act of 2019 S.3129 - Lower Costs, More Cures Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021

Contacted: Centers For Disease Control & Prevention (CDC); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA); State, Dept of (DOS); Natl Institutes of Health (NIH); White House Office; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Bills named: S. 2543 (116th), S. 3129 (116th), H.R. 259 (116th), H.R. 3 (116th), H.R. 133 (116th), H.R. 7647 (116th), H.R. 19 (116th)

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Contacted: U.S. Trade Representative (USTR); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Commerce, Dept of (DOC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; White House Office; Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Patent & Trademark Office (PTO)

Veterans VET

Education related to antivirals and oncology products.

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; State, Dept of (DOS); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries. Administration's Buy American initiatives.

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Centers For Disease Control & Prevention (CDC); White House Office; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of Management & Budget (OMB); U.S. Trade Representative (USTR)

Health Issues HCR

Advocate on drug pricing proposals, expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. Highlighting Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatment for COVID-19 (2019 Novel Coronavirus), including: clinical trials, expanded access, compassionate use program, emergency use authorization, donation, distribution and allocation, and reimbursement of Veklury (remdesivir). H.R.6201 - Families First Coronavirus Response Act S.3548 - CARES Act H.R.6800 - The Heroes Act H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S.2543 - Prescription Drug Pricing Reduction Act of 2019 S.3013 - Encouraging Innovate Benefit Design to Lower Costs for Seniors Act

Contacted: Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); State, Dept of (DOS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); White House Office; Office of the Vice President of the United States

Bills named: H.R. 6074 (116th), H.R. 6201 (116th), S. 2543 (116th), S. 3013 (116th), S. 3548 (116th), H.R. 6800 (116th)

Budget/Appropriations BUD

Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. H.R. 4378 - Continuing Appropriations Act and Health Extenders Act H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act H.R. 8337 - Continuing Appropriations Act of 2021 H.R. 133 - Consolidated Appropriations Act, 2021

Contacted: White House Office; Office of Management & Budget (OMB); State, Dept of (DOS); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Office of the Vice President of the United States

Bills named: H.R. 3055 (116th), H.R. 1865 (116th), H.R. 4378 (116th), H.R. 133 (116th), H.R. 8337 (116th)